fashion -WSS

fashion

author：hotspot 2025-08-12 09:09:29 - browse：8433

A group of four doctors gather around a hologram projecting different medical icons — health tech coverage from STAT — Adobe

DarioHealth, which makes apps for managing chronic diseases, today announced it will acquire digital mental health company Twill for $10 million in cash plus stock valued at over $20 million at the end of Tuesday trading. The move is a bet that a consolidated offering can attract a critical mass of large customers in a market where profits have been elusive.

Founded in 2011, Dario started with a diabetes app targeted at consumers before expanding it to hypertension and weight management. It still maintains that direct-to-consumer business but has since shifted its focus to selling its suite of offerings, including a musculoskeletal care program it acquired in 2021, to health plans and employers in the hopes of reaching much larger patient populations. Recent updates aimed at making itself attractive to clients include a new offering built around popular, and expensive, GLP-1 weight loss drugs, and published real world data suggesting its tools can save clients money on downstream health care costs. With Twill, Dario adds a mental health app and related services, addressing a top demand of employers.

Despite momentum, DarioHealth, which is publicly traded, is unprofitable, and by its own estimations on earnings calls last year, it remained a ways from that milestone. Before acquiring Twill, the company said that it expected the whole business to break even at about $80 million in revenue — about four times the roughly $20 million it projected for 2023. In November, the company reported that it lost over $40 million in the first nine months of 2023.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Unmasking the 'centricity' illusion in clinical trials

WSS

Some medical students still think black patients feel less pain

Medical device trials still don't enroll enough women, study finds

How faith leaders like me can help address America's obesity epidemic

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Medical students need to learn the potent medicine of empathy

NIH tests clinical research in primary care with $30 million program

hotspot

fashion

entertainment

Malaria cases in Florida and Texas: Here’s what you need to know

New report analyzes digital physical therapy solutions' effectiveness

ChatGPT in medicine: STAT answers readers' burning questions

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Duchenne breakthrough therapy leaves behind pioneering families

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Malaria cases in Florida and Texas: Here’s what you need to know

Why we need mandatory labeling of GMO products

Supreme Court strikes down use of affirmative action

Coercive sterilizations revealed by STAT prompt outrage

hotspot

New report analyzes digital physical therapy solutions' effectiveness

Lilly's Alzheimer's drug donanemab backed by FDA advisers

Readers discuss the intersection of pregnancy and addiction

Coercive sterilizations revealed by STAT prompt outrage

Lawsuit challenges CMS nursing home minimum staffing rule

Stephen Quake on the Chan Zuckerberg quest to conquer disease

focus

focus

hotspot

leisure time